Shangdon Weigo Group Medical Polymer Revenue, Profits - SHWGF Annual Income Statement

Add to My Stocks
$0.86 $0 (0%) SHWGF stock closing price Oct 12, 2018 (Closing)

Fundamental analysis of SHWGF stock involves analyzing its financial statements, apart from checking the Shangdon Weigo Group Medical Polymer stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement for SHWGF which shows a YOY revenue decline of -8.06% is specific to a period of time. Investors typically check YoY or QoQ revenue growth. Along with Shangdon Weigo Group Medical Polymer assets and Shangdon Weigo Group Medical Polymer free cash flow, Shangdon Weigo Group Medical Polymer profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $256.02M and the 2017 revenue is $931.31M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Shangdon Weigo Group Medical Polymer Revenues or Net Sales
931.31M1.01B942.29M857.64M745.51M585.46M492.98M
Cost Of Goods Sold (COGS)340.37M390.36M382.61M353.19M304.84M250.22M220.17M
Shangdon Weigo Group Medical Polymer Gross Profit
590.93M622.55M559.67M504.45M440.66M335.24M272.81M
Research & Development Expense40.52M45.55M46.59M38.69M33.76M27.07M-
Selling General & Admin Expense320.99M370.71M293.25M254.78M238.39M172.54M142.47M
Income Before Depreciation Depletion Amortization229.41M206.28M219.82M210.97M168.5M135.62M130.33M
Depreciation Depletion Amortization-------
Non Operating Income---0.13M--79.12M43.83M426.67M
Interest Expense3.53M8.54M7.08M3.68M1.44M--
Shangdon Weigo Group Medical Polymer Pretax Income
226.07M197.8M212.61M207.29M87.93M178.72M556.83M
Provision for Income Taxes33.21M26.6M29.71M29.38M25.28M20.6M19.29M
MinorityInterest-63.16M4.76M5.75M1.6M---
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations192.86M171.2M182.89M177.9M62.64M158.12M537.54M
Extraordinary Items & Discontinued Operations-------
Shangdon Weigo Group Medical Polymer Profit/ Loss (Net Income)
256.02M166.44M177.14M176.3M62.64M158.12M537.54M
Average Shares used to compute Diluted EPS4.48B4.48B4.48B4.52B4.48B4.53B-
Average Shares used to compute Basic EPS4.48B4.48B4.48B4.52B4.48B4.53B-
Income Before Nonrecurring Items185.97M166.44M178.35M173.97M65.75M158.12M-
Income from Nonrecurring Items-------
Shangdon Weigo Group Medical Polymer Earnings Per Share Basic Net
0.060.040.040.040.010.030.63
Shangdon Weigo Group Medical Polymer Earnings Per Share Diluted Net
0.060.040.040.040.010.03-
EPS Diluted Before Nonrecurring Items0.040.040.040.040.010.03-
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Before investing one should read a report on Shangdon Weigo Group Medical Polymer stock analysis. It helps to look at the following income statement items:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: Shangdon Weigo Group Medical Polymer revenue chart implies that the company is growing. It has not been the case with Shangdon Weigo Group Medical Polymer. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. SHWGF stock had a healthy bottom line growth.

The income statement is also called statement of revenue and expense. The SHWGF financials along with Shangdon Weigo Group Medical Polymer historical stock prices provide a lot of details about the firm.

Shangdon Weigo Group Medical Polymer Income Statement - Key Financial Ratios

Dividend Yield
0%